molecular function |
| GO:0031716 | | calcitonin receptor binding | | Interacting selectively and non-covalently with a calcitonin receptor. |
| GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
biological process |
| GO:0007190 | | activation of adenylate cyclase activity | | Any process that initiates the activity of the inactive enzyme adenylate cyclase. |
| GO:0032147 | | activation of protein kinase activity | | Any process that initiates the activity of an inactive protein kinase. |
| GO:0007189 | | adenylate cyclase-activating G-protein coupled receptor signaling pathway | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP). |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0001984 | | artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure | | An increase in the internal diameter of an artery, triggered by vasomotor suppression, during the chemoreceptor response to decreased blood pressure. |
| GO:0006874 | | cellular calcium ion homeostasis | | Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell. |
| GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| GO:1990090 | | cellular response to nerve growth factor stimulus | | A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus. |
| GO:0071356 | | cellular response to tumor necrosis factor | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
| GO:0050965 | | detection of temperature stimulus involved in sensory perception of pain | | The series of events involved in the perception of pain in which a temperature stimulus is received and converted into a molecular signal. |
| GO:0007566 | | embryo implantation | | Attachment of the blastocyst to the uterine lining. |
| GO:0007631 | | feeding behavior | | Behavior associated with the intake of food. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0002548 | | monocyte chemotaxis | | The movement of a monocyte in response to an external stimulus. |
| GO:0045776 | | negative regulation of blood pressure | | Any process in which the force of blood traveling through the circulatory system is decreased. |
| GO:0045779 | | negative regulation of bone resorption | | Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption. |
| GO:0031645 | | negative regulation of neurological system process | | Any process that stops, prevents, or reduces the frequency, rate or extent of a neurophysiological process. |
| GO:0030279 | | negative regulation of ossification | | Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation. |
| GO:0045986 | | negative regulation of smooth muscle contraction | | Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0007218 | | neuropeptide signaling pathway | | The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor. |
| GO:0045762 | | positive regulation of adenylate cyclase activity | | Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity. |
| GO:0007204 | | positive regulation of cytosolic calcium ion concentration | | Any process that increases the concentration of calcium ions in the cytosol. |
| GO:0051482 | | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway | | Any process that increases the concentration of calcium ions in the cytosol that occurs as part of a PLC-activating G-protein coupled receptor signaling pathway. G-protein-activated PLC hydrolyses phosphatidylinositol-bisphosphate (PIP2) to release diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 then binds to calcium release channels in the endoplasmic reticulum (ER) to trigger calcium ion release into the cytosol. |
| GO:0045778 | | positive regulation of ossification | | Any process that activates or increases the frequency, rate or extent of bone formation. |
| GO:0008016 | | regulation of heart contraction | | Any process that modulates the frequency, rate or extent of heart contraction. Heart contraction is the process in which the heart decreases in volume in a characteristic way to propel blood through the body. |
| GO:0002027 | | regulation of heart rate | | Any process that modulates the frequency or rate of heart contraction. |
| GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0048265 | | response to pain | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. |
| GO:0042311 | | vasodilation | | An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. |
cellular component |
| GO:0030424 | | axon | | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0043195 | | terminal bouton | | Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. |